跳至主要内容
临床试验/JPRN-jRCTs041230038
JPRN-jRCTs041230038招募中1 期

Verification of immunoregulatory effect of the supplement Ascophyllan HS

Mizuno Shohei0 个研究点目标入组 12 人开始时间: 2023年6月16日最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 60age old(—)
性别
All

入选标准

  • 20 to 60 years of age with no subjective symptoms (symptoms caused by any disease).
  • Drinking habit less than 3 times a week, up to 180 ml of sake (beer: 500 ml, wine: 180 ml, shochu: 110 ml, whiskey: 60 ml).
  • Normal liver and kidney function within the last year.
  • Body Mass Index: greater than 16 and less than 25.
  • Written explanation and written consent have been obtained.
  • Employees in Aichi Medical University or their referrals.
  • Usually one bowel movement within 3 days.

排除标准

  • Currently receiving drug therapy.
  • Currently suffering from a chronic disease (cardiac, pulmonary, renal, gastrointestinal, inflammatory, etc.)
  • Invasive cancer within the last 5 years.
  • Non-invasive cancer within the last 1 year.
  • Smoked within the last year.
  • Taken health foods, supplements, or vitamins containing ascophyllan within the last 2 weeks.
  • Pregnant or breastfeeding women.
  • History of hypersensitivity to supplements containing ascophyllan.
  • Student at Aichi Medical University.
  • Inappropriate by the study investigator.

研究者

发起方
Mizuno Shohei

相似试验

Immunoregulatory effect of Ascophyllan HS | 临床试验